Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Registration Form 2007

Mar 7, 2007

29777_rf_2007-03-07_9aaa253f-d4bf-46fd-b50a-115450049fc7.zip

Registration Form

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

S-8 1 a07-4861_2s8.htm S-8

*As filed with the Securities and Exchange Commission on March 7, 2007.*

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM S-8*

*REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State or other
jurisdiction of (I.R.S. Employer
incorporation or
organization) Identification
No.)
Abbott
Laboratories
100
Abbott Park Road 60064-6400
Abbott
Park, Illinois (Zip Code)
(Address of
Principal Executive Offices)

*ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM*

(Full title of the plan)

*Laura J. Schumacher*

*Abbott Laboratories*

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Name and address of agent for service)

Telephone number, including area code, of agent for service: (847) 937-6100

*CALCULATION OF REGISTRATION FEE*

Title of securities to be registered Amount to be registered Proposed maximum offering price per share (a) Proposed maximum aggregate offering price (a) Amount of registration fee (a)
Common shares
(without par value) 14,000,000 $ 52.725 $ 738,150,000 $ 22,661

(a) In addition, pursuant to Rule 416(c) under the Securities Act of 1933, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plan described herein. The filing fee has been calculated in accordance with Rule 457(c) based on the average of the high and low prices of Registrant’s Common Shares reported on the New York Stock Exchange on March 6, 2007.

SEQ.=1,FOLIO='',FILE='C:\fc\66145551948_D10967_1825347\4861-2-bb.htm',USER='jmsproofassembler',CD='Mar 7 14:55 2007'

Pursuant to General Instruction E, the contents of Abbott Laboratories Stock Retirement Program Registration Statement on Form S-8 (File no. 33-50452) are incorporated herein by reference.

| Part II. Information Required in the Registration
Statement |
| --- |
| Item 5.Interests of Named Experts and Counsel |

Laura J. Schumacher, Esq., Executive Vice President, General Counsel and Secretary of the Registrant, whose opinion is included herewith as Exhibit 5, beneficially owned as of February 28, 2007, approximately 121,614 Common Shares of the Registrant (this amount includes approximately 4,934 shares held for the benefit of Ms. Schumacher in the Abbott Laboratories Stock Retirement Trust pursuant to the Abbott Laboratories Stock Retirement Plan) and held options to acquire 377,329 Common Shares of which options to purchase 186,995 Common Shares are currently exercisable.

Item 8. Exhibits

Reference is made to the Exhibit Index which is incorporated herein by reference. Neither an opinion of counsel concerning the Program’s compliance with the requirements of ERISA nor an Internal Revenue Service (“IRS”) determination letter is furnished because the Registrant undertakes that it will submit, or has submitted, the Abbott Laboratories Stock Retirement Program and any amendments thereto to the IRS in a timely manner and has made or will make all changes required by the IRS in order to qualify the Program.

2

SEQ.=1,FOLIO='2',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'

SIGNATURES

THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on February 28, 2007.

ABBOTT LABORATORIES
By: /s/ MILES D. WHITE
Miles
D. White,
Chairman
of the Board and
Chief
Executive Officer

3

SEQ.=1,FOLIO='3',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
Chairman of
the Board, February 28, 2007
/s/ MILES D. WHITE Chief
Executive Officer, and
Miles D. White Director
President and
Chief
Operating
Officer, February 28, 2007
/s/ RICHARD A. GONZALEZ and Director
Richard A. Gonzalez
Executive
Vice President, Finance and February 28, 2007
/s/ THOMAS C. FREYMAN Chief
Financial Officer (Principal
Thomas C. Freyman Financial
Officer)
Vice
President and Controller February 28, 2007
/s/ GREG W. LINDER (Principal
Accounting Officer)
Greg W. Linder
/s/ ROXANNE S. AUSTIN Director
Roxanne S. Austin February 28, 2007
/s/ WILLIAM M. DALEY Director
William M. Daley February 28, 2007
/s/ W. JAMES FARRELL Director February 28, 2007
W. James Farrell

4

SEQ.=1,FOLIO='4',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'

/s/ H. LAURANCE FULLER Director February 28, 2007
H. Laurance Fuller
/s/ JACK M. GREENBERG Director February 28, 2007
Jack M. Greenberg
/s/ DAVID A. L. OWEN Director February 28, 2007
David A. L. Owen
/s/ BOONE POWELL JR. Director February 28, 2007
Boone Powell Jr.
/s/ W. ANN REYNOLDS Director February 28, 2007
W. Ann Reynolds
/s/ ROY S. ROBERTS Director February 28, 2007
Roy S. Roberts
/s/ WILLIAM D. SMITHBURG Director February 28, 2007
William D. Smithburg

5

SEQ.=1,FOLIO='5',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'

THE PLAN. Pursuant to the requirements of the Securities Act of 1933, the Abbott Laboratories Stock Retirement Program has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on the 28 th day of February, 2007.

| ABBOTT LABORATORIES
STOCK RETIREMENT PROGRAM | |
| --- | --- |
| By: | /s/ STEPHEN R. FUSSELL |
| | Stephen R. Fussell,
Plan Administrator |

6

SEQ.=1,FOLIO='6',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'

EXHIBIT INDEX

Exhibit No. Description
4 Abbott Laboratories
Stock Retirement Program.
5 Opinion of Laura J.
Schumacher.
23.1 The consent of counsel,
Laura J. Schumacher, is included in her opinion.
23.2 Consent of Deloitte
& Touche LLP.
23.3 Consent of Deloitte
& Touche LLP.
24 Power of Attorney is included on the signature page.

7

SEQ.=1,FOLIO='7',FILE='C:\fc\66114031146_D11265_1824298\4861-2-bd.htm',USER='jmsproofassembler',CD='Mar 7 11:40 2007'